Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.

Khanna G, O'Dorisio MS, Menda Y, Glasier C, Deyoung B, Smith BJ, Graham M, Juweid M.

Pediatr Blood Cancer. 2008 Mar;50(3):561-6.

PMID:
17387742
3.

111In-pentetreotide scintigraphy in medulloblastoma: a comparison with magnetic resonance imaging.

Yüksel M, Lutterbey G, Biersack HJ, Elke U, Hasan C, Gao Z, Bode U, Ezziddin S.

Acta Oncol. 2007;46(1):111-7.

PMID:
17438713
4.

Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma.

Klutmann S, Bohuslavizki KH, Brenner W, Behnke A, Tietje N, Kröger S, Hugo HH, Mehdorn HM, Clausen M, Henze E.

J Nucl Med. 1998 Nov;39(11):1913-7.

5.

Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study.

Dörr U, Würstlin S, Frank-Raue K, Raue F, Hehrmann R, Iser G, Scholz M, Guhl L, Buhr HJ, Bihl H.

Horm Metab Res Suppl. 1993;27:48-55.

PMID:
8330872
6.

Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.

Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, Pisu N, Madeddu G, Delle Fave G, Madeddu G.

J Nucl Med. 2003 Mar;44(3):359-68.

7.

Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.

Namwongprom S, Wong FC, Tateishi U, Kim EE, Boonyaprapa S.

Ann Nucl Med. 2008 May;22(4):237-43. doi: 10.1007/s12149-007-0123-y. Epub 2008 Jun 6.

PMID:
18535873
8.

[Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].

Kaszper E, Hanzély Z, Szende B, Dabasi G, Garami M, Schuler D, Hauser P.

Magy Onkol. 2008 Dec;52(4):351-5. doi: 10.1556/MOnkol.52.2008.4.3. Hungarian.

PMID:
19068462
9.

A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma.

Müller HL, Frühwald MC, Scheubeck M, Rendl J, Warmuth-Metz M, Sörensen N, Kühl J, Reubi JC.

J Neurooncol. 1998 May;38(1):27-40.

PMID:
9540055
10.

Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.

Lee JD, Kim DI, Lee JT, Chang JW, Park CY.

J Nucl Med. 1995 Apr;36(4):537-41.

11.

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.

Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, Mignon M, le Guludec D.

J Nucl Med. 1997 Jun;38(6):853-8.

12.

Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.

Gibril F, Reynolds JC, Chen CC, Yu F, Goebel SU, Serrano J, Doppman JL, Jensen RT.

J Nucl Med. 1999 Apr;40(4):539-53.

13.

[Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].

Banzo J, Abós MD, Prats E, García F, Freile E, Razola P, Escalera T.

Rev Esp Med Nucl. 2001 Oct;20(6):431-8. Spanish.

14.
15.

[Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].

Hoefer M, Schmidt S, Welter J, Kirsch CM, Ukena D, Sybrecht GW.

Pneumologie. 1998 Feb;52(2):106-12. German.

PMID:
9557059
16.

Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas.

Meewes C, Bohuslavizki KH, Krisch B, Held-Feindt J, Henze E, Clausen M.

J Nucl Med. 2001 Sep;42(9):1338-45.

17.

Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT.

Tie J, Gunawardana DH, Rosenthal MA.

J Clin Neurosci. 2008 Dec;15(12):1327-34. doi: 10.1016/j.jocn.2007.12.008. Epub 2008 Oct 8.

PMID:
18845440
18.

Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.

Rostomily RC, Elias M, Deng M, Elias P, Born DE, Muballe D, Silbergeld DL, Futran N, Weymuller EA, Mankoff DA, Eary J.

Head Neck. 2006 Apr;28(4):305-12.

PMID:
16470879
19.

Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma.

Klutmann S, Bohuslavizki KH, Tietje N, Kröger S, Behnke A, Brenner W, Mester J, Henze E, Clausen M.

J Nucl Med. 1999 Aug;40(8):1246-51.

20.

Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

Dromain C, de Baere T, Lumbroso J, Caillet H, Laplanche A, Boige V, Ducreux M, Duvillard P, Elias D, Schlumberger M, Sigal R, Baudin E.

J Clin Oncol. 2005 Jan 1;23(1):70-8.

Items per page

Supplemental Content

Write to the Help Desk